Buprenorphine transdermal skin patch and Dexrazoxane Intravenous
Determining the interaction of Buprenorphine transdermal skin patch and Dexrazoxane Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Dextenza Insert
- Buprenorphine transdermal skin patch-Dextenza intraocular
- Buprenorphine transdermal skin patch-Dextran 40
- Buprenorphine transdermal skin patch-Dextran 70 6% in 5% Dextrose high molecular weight
- Buprenorphine transdermal skin patch-Dextran 75
- Buprenorphine transdermal skin patch-Dextran high molecular weight
- Dexrazoxane Intravenous-Buprenorphine, Buprenorphine Hydrochloride
- Dexrazoxane Intravenous-Buprenorphine/naloxone Oromucosal, Sublingual
- Dexrazoxane Intravenous-Buproban
- Dexrazoxane Intravenous-Bupropion
- Dexrazoxane Intravenous-Bupropion and naltrexone
- Dexrazoxane Intravenous-Bupropion Extended-Release Tablets